Major depression in renal dialysis patients: an open trial of antidepressant therapy - PubMed (original) (raw)
Affiliations
- PMID: 2644243
Clinical Trial
Major depression in renal dialysis patients: an open trial of antidepressant therapy
S H Kennedy et al. J Clin Psychiatry. 1989 Feb.
Erratum in
- J Clin Psychiatry 1989 Apr;50(4):148. Roin GM [corrected to Rodin GM]
Abstract
Eight patients receiving renal dialysis who had concurrent major depression were treated with antidepressant therapy for 7 weeks under controlled clinical conditions. The treatment resulted in a clinically significant recovery from the depression in five patients, improvement in one, and discontinuation of the therapy in the other two. Systematic examination for depression in dialysis patients and the judicious use of an antidepressant such as desipramine are important.
Similar articles
- Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Schmauss M, Laakmann G, Dieterle D, Blaschke D. Schmauss M, et al. Pharmacopsychiatry. 1985 Jul;18(4):282-5. doi: 10.1055/s-2007-1017382. Pharmacopsychiatry. 1985. PMID: 3895255 Clinical Trial. - Diagnosis and treatment of depression in dialysis patients.
Kimura H, Ozaki N. Kimura H, et al. Ther Apher Dial. 2006 Aug;10(4):328-32. doi: 10.1111/j.1744-9987.2006.00385.x. Ther Apher Dial. 2006. PMID: 16911185 Review. - Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
Aberg A. Aberg A. Acta Psychiatr Scand Suppl. 1981;290:244-55. Acta Psychiatr Scand Suppl. 1981. PMID: 6452794 Clinical Trial. - Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J. Revicki DA, et al. J Fam Pract. 1998 Dec;47(6):446-52. J Fam Pract. 1998. PMID: 9866670 Clinical Trial. - Efficacy issues with antidepressants.
Fawcett J, Barkin RL. Fawcett J, et al. J Clin Psychiatry. 1997;58 Suppl 6:32-9. J Clin Psychiatry. 1997. PMID: 9227671 Review.
Cited by
- The influence of cognitive-behavioral therapy on depression in dialysis patients - meta-analysis.
Zegarow P, Manczak M, Rysz J, Olszewski R. Zegarow P, et al. Arch Med Sci. 2020 Jan 16;16(6):1271-1278. doi: 10.5114/aoms.2019.88019. eCollection 2020. Arch Med Sci. 2020. PMID: 33224325 Free PMC article. Review. - Prevalence and risk factors of depressive symptoms among dialysis patients with end-stage renal disease (ESRD) in Khartoum, Sudan: A cross-sectional study.
Elkheir HK, Wagaella AS, Badi S, Khalil A, Elzubair TH, Khalil A, Ahmed MH. Elkheir HK, et al. J Family Med Prim Care. 2020 Jul 30;9(7):3639-3643. doi: 10.4103/jfmpc.jfmpc_1229_19. eCollection 2020 Jul. J Family Med Prim Care. 2020. PMID: 33102343 Free PMC article. - Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.
Gregg LP, Hedayati SS. Gregg LP, et al. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):457-464. doi: 10.1097/MNH.0000000000000629. Curr Opin Nephrol Hypertens. 2020. PMID: 32701597 Free PMC article. Review. - Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States.
Vadiei N, Bhattacharjee S. Vadiei N, et al. Int Urol Nephrol. 2019 Feb;51(2):303-309. doi: 10.1007/s11255-018-2034-3. Epub 2018 Dec 4. Int Urol Nephrol. 2019. PMID: 30515735 - Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management.
Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F, Ricardo AC. Shirazian S, et al. Kidney Int Rep. 2016 Sep 20;2(1):94-107. doi: 10.1016/j.ekir.2016.09.005. eCollection 2017 Jan. Kidney Int Rep. 2016. PMID: 29318209 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical